• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

QuintilesIMS 在中国的扩张足迹

QuintilesIMS自1994年在中国开展业务,作为一个全球化的医疗健康领域服务商,QuintilesIMS中国公司充分运用其丰富的行业经验和领先的技术,迅速扩张业务版图,达到中国医院渠道和零售渠道的数据信息全面覆盖,实现中国医院市场全景解析。随着循证医学的率先引入,QuintilesIMS中国公司不断加强在医药行业咨询领域的投入,结合强大的全球数据资产、丰富的项目经验和专业的团队,在中国形成了能够提供覆盖全行业、跨职能且贯穿产品整个生命周期的全方位、高质量的咨询服务。

现在:作为中国医疗健康领域的思想领袖,QuintilesIMS中国致力于为客户提供所需要的市场情报,帮助他们的商业决策制定。

  • 2012:IMS PharmaTrendTM National Audit上市,全面解读中国OTC市场

IMS CHPA 地域覆盖扩广至省级报告
QuintilesIMS 中国获得ISO 9001:2008质量认证

  • 2004:通过收购进入消费者健康市场,全面覆盖中国药品市场的医院和零售渠道
  • 2002:在中国引入循证咨询服务
  • 1999:在中国首先发布了针对全国医院市场的用药统计报告:IMS中国医院药品统计报告(IMS CHPA)
  • 1994:QuintilesIMS 中国:业务展开,推出了上海医药用品统计报告